SAM
WST icon

Shell Asset Management’s West Pharmaceutical WST Stock Holding History

Shell Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$504K Sell
1,923
-1,219
-39% -$296K 0.05% 339
2025
Q2 		$687K Buy
3,142
+1,632
+108% +$349K 0.02% 437
2025
Q1 		$338K Sell
1,510
-9
-0.6% -$2.48K 0.02% 581
2024
Q4 		$498K Sell
1,519
-76
-5% -$23.9K 0.02% 495
2024
Q3 		$479K Buy
+1,595
New +$488K 0.02% 504
2024
Q1 		$530K Sell
1,608
-1,241
-44% -$459K 0.02% 448
2023
Q4 		$1M Sell
2,849
-984
-26% -$348K 0.05% 331
2023
Q3 		$1.44M Sell
3,833
-87
-2% -$33.6K 0.06% 296
2023
Q2 		$1.5M Sell
3,920
-1,429
-27% -$510K 0.06% 292
2023
Q1 		$1.85M Sell
5,349
-58
-1% -$16.9K 0.08% 254
2022
Q4 		$1.27M Sell
5,407
-1,003
-16% -$238K 0.06% 323
2022
Q3 		$1.58M Sell
6,410
-1,373
-18% -$418K 0.06% 300
2022
Q2 		$2.35M Sell
7,783
-2,672
-26% -$869K 0.07% 276
2022
Q1 		$4.29M Sell
10,455
-29
-0.3% -$11.4K 0.1% 206
2021
Q4 		$4.92M Sell
10,484
-2,980
-22% -$1.28M 0.1% 203
2021
Q3 		$5.72M Sell
13,464
-5,675
-30% -$2.39M 0.13% 171
2021
Q2 		$6.87M Buy
19,139
+1,416
+8% +$468K 0.13% 168
2021
Q1 		$4.99M Buy
17,723
+9,588
+118% +$2.74M 0.1% 230
2020
Q4 		$2.31M Buy
8,135
+3,007
+59% +$844K 0.05% 364
2020
Q3 		$1.41M Buy
5,128
+592
+13% +$157K 0.03% 392
2020
Q2 		$1.03M Sell
4,536
-4,561
-50% -$896K 0.03% 429
2020
Q1 		$1.39M Sell
9,097
-107
-1% -$16.5K 0.04% 359
2019
Q4 		$1.38M Buy
9,204
+1,854
+25% +$270K 0.03% 444
2019
Q3 		$1.04M Sell
7,350
-63
-0.8% -$8.67K 0.02% 517
2019
Q2 		$928K Sell
7,413
-168
-2% -$19.8K 0.02% 597
2019
Q1 		$835K Hold
7,581
– – 0.02% 658
2018
Q4 		$743K Sell
7,581
-600
-7% -$65.1K 0.02% 654
2018
Q3 		$1.01M Buy
+8,181
New +$917K 0.02% 659

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Shell Asset Management's WST Position: Q3 2025 in Review

Shell Asset Management reduced its West Pharmaceutical (WST) stake by 39% in Q3 2025, selling an estimated $296K and leaving 1,923 shares worth $504K. The position accounts for 0.05% of the portfolio, ranked #339.

Shell Asset Management first reported a position in WST in Q3 2018 and has held it in 28 quarters since. The position peaked at $6.87M in Q2 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Shell Asset Management held 1,923 shares of West Pharmaceutical worth $504K as of Q3 2025.
  • Shell Asset Management sold 1,219 West Pharmaceutical shares in Q3 2025, an estimated $296K.
  • West Pharmaceutical made up 0.05% of Shell Asset Management's portfolio in Q3 2025, its #339 holding.
  • Shell Asset Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 28 quarters since.
  • Shell Asset Management's West Pharmaceutical position peaked at $6.87M in Q2 2021.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.